Petros Pharmaceuticals, Inc.
PTPI· OTC
PTPIPetros Pharmaceuticals, Inc.
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001410578-22-003441
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | — | $2.15M | $3.46M |
| Net Income | -$13.83M | -$1.70M | -$3.30M |
| EPS Diluted | -$6.69 | -$0.17 | -$0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petros Pharmaceuticals, Inc. · CIK 1815903 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end
